Agios turns to Alnylam for help with rare disease push
BioPharma
Source: biopharmadive.com
Page 7 - Brian Goff News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Brian Goff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Brian Goff Today - Breaking & Trending Today
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) CEO Sells $324,693.64 in Stock
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) CEO Brian Goff sold 11,449 shares of Agios Pharmaceuticals stock in a transaction dated Friday, June 30th. The stock was sold at an average price of $28.36, for a total value of $324,693.64. Following the completion of the transaction, the chief executive officer now directly owns 14,079 shares […]
Source: themarketsdaily.com
Agios Pharmaceuticals (NASDAQ:AGIO) Shares Down 4.1%
Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) dropped 4.1% during trading on Thursday . The company traded as low as $27.94 and last traded at $28.00. Approximately 334,693 shares traded hands during mid-day trading, a decline of 34% from the average daily volume of 505,727 shares. The stock had previously closed at $29.19. […]
Source: themarketsdaily.com
Agios Appoints Catherine Owen to Board of Directors
25.05.2023 - – John Maraganore Completes Tenure on Agios Board After Nearly a Dozen Years of Service – – Kaye Foster to Be Appointed Lead Independent Director – CAMBRIDGE, Mass., May 25, 2023 (GLOBE NEWSWIRE) - Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), ... Seite 1
Source: wallstreet-online.de
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Agios' First Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end.
Source: insidermonkey.com